New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

Second study to be presented at the 2nd European Congress on Dermato-Oncology demonstrates DecisionDx-Melanoma can identify ...

India's newest health surveillance weapon isn't human — it's an AI tool that flagged over 5,000 risks: Report

An AI tool, launched in 2022, has significantly increased the efficiency of health surveillance by issuing real-time alerts ...